Marc Scheineson comments on how the U.S. Food and Drug Administration could help overcome disruptions to the pharmaceutical supply chain caused by the coronavirus.
In the News
March 4, 2020
Modern Healthcare | Coronavirus Strains Fragile Pharmaceutical Supply Chain
Media Contact